Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine

Clin Infect Dis. 2011 Jul 15;53(2):207-8. doi: 10.1093/cid/cir282.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza A Virus, H3N2 Subtype / immunology
  • Influenza A Virus, H3N2 Subtype / isolation & purification
  • Influenza B virus / immunology
  • Influenza B virus / isolation & purification
  • Influenza Vaccines / immunology*
  • Influenza, Human / epidemiology*
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Prevalence
  • United States / epidemiology
  • Vaccines, Attenuated / immunology

Substances

  • Influenza Vaccines
  • Vaccines, Attenuated